Regulations.gov document
Reference 11 Riviere 2014 re Testing of Retroviral Vector-Based Human Gene Therapy…
Supporting & Related Material · FDA-1999-D-0081 · posted Jul 12, 2018
Key facts
| Document ID | FDA-1999-D-0081-0017 |
|---|---|
| Title | Reference 11 Riviere 2014 re Testing of Retroviral Vector-Based Human Gene Therapy Products for Replication Competent Retrovirus During Product Manufacture and Patient Follow-up Draft Guidance for Industry |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-1999-D-0081 |
| Posted | Jul 12, 2018 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: